A fluorescence imaging system (Xillix LIFE Lung Fluorescence Endoscopy system) using fluorescence for the accurate diagnosis and early detection of lesions through an endosocope has been developed. This system has applied an optical diagnostic technology to functionally diagnose lesions which have been difficult to morphologically recognize or are occult with conventional endoscope. The benefit of this system in the diagnosis of lung cancer has already been confirmed in the US and Japan, and feasibility of the system in the gastric intestinal field has also been evaluated.
INTRODUCTION
By adopting spectroscopic technologies such as fluorescence of light, absorption of light, and Raman-scattered light, abnormalities of living tissue can be detected on the cellular or macroscopic level. Recently, a new technology, optical diagnosis, has been calling attention that applies the above spectroscopic technologies to the "living body as it is" to functionally diagnose lesions that have been difficult to be determined by conventional morphological diagnosis [1] [2] [3] [4] . Particularly, research and development of "fluorescence imaging" and "optical biopsy" have been actively implemented: fluorescence imaging has been developed in view ofearly detection and diagnosis of lesions, that have been difficult to detect with conventional endoscopy.
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This has been done by means of displaying in vivo video images endoscopically using autofluorescence emitted from living tissue. Emitted autofluorescence is a result of when a light of specific wavelength (light between UV and blue region) excites tissue. This can be done without using drugs such as photosensitizing substances [5] [6] [7] . Optical biopsy has been developed to provide pathological diagnosis with an optical fiber inserted through an endoscope channel, in place of biopsy [8, 9] . These autofluorescence technologies are expected to be established in the near future as a new diagnosing method in conjunction with an endoscopic fluorescence imaging endoscopes.
As stated above, development of an endoscopic fluorescence imaging system has been conducted to endoscopically display image of autofluorescence 60 S. TAKEHANA et al.
to provide new diagnostic form by exploiting the difference between the spectrums of normal and abnormal tissue [10, 11] .
MATERIALS AND METHODS

Overview of the Device
The LIFE-Lung system was first developed in the world by Xillix Technologies Corp., Canada, in 1990, and the system was found to be useful in detecting early lesion [10] [11] [12] . This Figure 3 is the result of autofluorescence spectrum measured ofnormal and abnormal tissue when blue light was illuminated to those living tissues through an optical fiber inserted into the endoscope channel [5, 6] . of 442 nm (He-Cd laser). While in normal tissue, the shape of fluorescence spectrum demonstrated its peak in green with gradual decrease at longer wavelength, the shape of overall spectrum in abnormal tissue was rather flat with decreased spectrum centering to the short wavelength side and with a small rise in red side.
Although the precise mechanism of different autofluorescence spectrums detected in normal and cancerous tissue has not been established, the following has been considered: It has been considered highly possible that collagen, flavoprotein, NADH, and porphyrin, known as autofluorescence substances existing in the living tissue, have something to do with the different spectrums as has the tissue architecture and the blood content.
With this LIFE-Lung, it has been considered that the system observes the following differences based on the wavelength excited/detected from the above substances.
( compared to conventional white-light bronchoscopy alone, detection ratio of metaplasia and cancer was improved from 65% to 90%, and that specificity was improved from 71% to 77.4% by using autofluorescence bronchoscopy jointly with conventional bronchoscopy. Ikeda et al. also report that detection ratio for metaplasia was improved from 28% to 96% by the joint use of autofluorescence bronchoscopy with conventional bronchoscopy than by the latter only. Since a screening test using sputum cytology has been carried out particularly in Japan, the LIFE-Lung is expected to serve in diagnosis of early lung cancer in subjects who have turned out to be positive in the sputum cytology.
Application to GI Figure 4 shows autofluorescence spectrum of normal and abnormal (precancerous) 
